Lexicon Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 1995-01-01
- Employees
- 285
- Market Cap
- $621.7M
- Website
- http://www.lexpharma.com
- Introduction
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company...
Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2010-03-03
- Lead Sponsor
- Lexicon Pharmaceuticals
- Target Recruit Count
- 103
- Registration Number
- NCT00691808
- Locations
- 🇳🇱
Pharmaceutical Research Associates Group BV, Zuidlaren, Netherlands
🇳🇱Kendle Netherlands, Utrecht, Netherlands
© Copyright 2024. All Rights Reserved by MedPath